comprehensive -WSS

comprehensive

author：explore 2025-09-29 19:57:39 - browse：73

Adam's take main illustration — Molly Ferguson/STAT

Behind the stellar commercial launch of Amylyx Pharmaceuticals’ treatment for ALS lies an uncomfortable question: Does early success of the drug, called Relyvrio, make it more complicated, perhaps impossible, to pull it from the market if we find out next year that it doesn’t work?

On Monday night, Amylyx said Relyvrio sales totaled $22 million in 2022 — a period that covers slightly more than one calendar quarter given the drug’s U.S. approval last September. The company said approximately 1,300 ALS patients were on Relyvrio at the end of December, and it expects that number to at least double by the end of the first quarter.

“We’re probably going to double, closer to triple, our revenue in Q1,” said James Frates, Amylyx’s chief financial officer, speaking on Monday night’s conference call.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Why do women spend more than men on medical expenses?

WSS

RaDonda Vaught case: a double standard for nurses, physicians

Pfizer's Covid pill remains 89% effective in final analysis, company says

Australia's humpback populations rebound raising hopes of marine scientists

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Listen: Biogen's messy board & Laronde's data problem

Meta looks to target Twitter with a rival app called Threads

entertainment

comprehensive

Wikipedia

Cancer drug shortages should be causing more outrage

Why do women spend more than men on medical expenses?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Connecting traumatic brain injury and domestic violence

Continuity nursing helped my family in our darkest PICU moments

Pfizer's Covid pill remains 89% effective in final analysis, company says

How to save PrEP access — and even expand it

Health tech startups drop sharply from 2021 highs

Walensky prepares to leave CDC — and Congress — behind

Inequities make cancer less preventable for women: report

explore

These geoengineering technologies could help combat the climate crisis, scientists say

Inequities make cancer less preventable for women: report

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Inside the fall of star MIT scientist David Sabatini

After a drawn out lobbying fight, ARPA

leisure time

Wikipedia

focus

Wikipedia